PetVivo Holdings, Inc.

PETV ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2018
Revenue $1.1M $1.1M $968.7K $917.2K $115.6K $12.6K $3.6K $1.5K
Cost of Revenue $386.9K $137.7K $101.8K $221.0K $201.2K $10.7K $19.7K
Gross Profit $754.8K $994.9K $866.9K $696.1K $-85.6K $1.9K $-16.1K $1.5K
Gross Margin 66.1% 87.8% 89.5% 75.9% -74.0% 15.0% -449.3% 100.0%
Operating Expenses
Research & Development $1.4M $1.6M $1.4M $996.4K $474.9K $98.2K $12.7K $118.9K
SG&A Expense $4.3M $4.8M $6.7M $5.0M $3.1M $1.8M $1.8M $2.2M
Operating Income $-9.1M $-8.1M $-10.6M $-8.7M $-5.1M $-2.0M $-2.0M $-2.3M
Operating Margin -793.9% -711.3% -1,096.4% -952.2% -4,374.7% -15,574.7% -56,191.0% -151,345.5%
Interest Expense $12.7K $6.1K $228.6K $32.2K $74.0K
Pretax Income $-10.5M $-8.4M $-11.0M $-8.7M $-5.0M $-3.5M $-2.1M $-2.3M
Income Tax Expense
Net Income $-10.5M $-8.4M $-11.0M $-8.7M $-5.0M $-3.5M $-2.1M $-2.3M
Net Margin -917.4% -741.6% -1,130.9% -950.5% -4,338.8% -28,007.5% -58,047.2% -154,790.6%
EPS (Basic) $-0.38 $-0.41 $-0.78 $-0.85 $-0.57 $-0.57 $-0.39 $-0.14
EPS (Diluted) $-0.38 $-0.41 $-0.78 $-0.85 $-0.57 $-0.39 $-0.14
Shares Outstanding (Basic) 30.2M 20.5M 14.0M 10.2M 8.8M 6.2M 23.1M 18.3M
Shares Outstanding (Diluted) 30.2M 20.5M 14.0M 10.2M 8.8M 6.2M 23.1M 18.3M
Dividends Per Share
← Newer Page 1 of 2 Older →